Histogen Inc.
HSTO · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Revenue | $5 | $5 | $5 | $4 |
| % Growth | 0% | 0% | 25% | – |
| Cost of Goods Sold | $62 | $38 | $38 | $38 |
| Gross Profit | -$57 | -$33 | -$33 | -$34 |
| % Margin | -1,140% | -660% | -660% | -850% |
| R&D Expenses | $660 | $536 | $993 | $1,089 |
| G&A Expenses | $2,870 | $1,557 | $2,486 | $1,883 |
| SG&A Expenses | $2,870 | $1,557 | $2,486 | $1,883 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $3,530 | $2,093 | $3,479 | $2,972 |
| Operating Income | -$3,525 | -$2,088 | -$3,474 | -$2,968 |
| % Margin | -70,500% | -41,760% | -69,480% | -74,200% |
| Other Income/Exp. Net | -$329 | -$1 | $1 | $1 |
| Pre-Tax Income | -$3,854 | -$2,089 | -$3,474 | -$2,967 |
| Tax Expense | $0 | $0 | -$1 | $0 |
| Net Income | -$3,851 | -$2,092 | -$3,473 | -$2,987 |
| % Margin | -77,020% | -41,840% | -69,460% | -74,675% |
| EPS | -0.9 | -0.49 | -0.81 | -0.93 |
| % Growth | -83.7% | 39.5% | 12.9% | – |
| EPS Diluted | -0.9 | -0.49 | -0.81 | -0.93 |
| Weighted Avg Shares Out | 4,272 | 4,272 | 4,272 | 3,211 |
| Weighted Avg Shares Out Dil | 4,272 | 4,272 | 4,272 | 3,211 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $1 |
| Interest Expense | $0 | $1 | $0 | $0 |
| Depreciation & Amortization | $24 | $38 | $38 | $38 |
| EBITDA | -$3,830 | -$2,050 | -$3,436 | -$2,930 |
| % Margin | -76,600% | -41,000% | -68,720% | -73,250% |